Resectable Non-Small Cell Lung Cancer
Вставка
- Опубліковано 31 жов 2023
- Resectable Non-Small Cell Lung Cancer: The Role of Biomarker Testing and Evaluation of Pathological Response Following Neoadjuvant Treatment is a short, targeted online microlearning course designed to engage pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team in improving the diagnosis, biomarker testing, and treatment of patients with non-small cell lung cancer (NSCLC) and melanoma. Each course offers 0.5 CME/CMLE credits.
These activities are funded by an independent educational grant from Bristol Myers Squibb.
Learn more at www.ascp.org/content/learning.... - Наука та технологія
